The different fertility preservation options that may be offered to patients before the initiation of chemo- and/or radiotherapy include cryopreservation of embryos, oocytes, or ovarian cortical tissue.^3,4 Decision-making in this area is particularly difficult because of the experimental nature of some of the techniques involved. With the continued development and optimization of these techniques, however, it may one day be possible to offer an individualized approach to management.^5,6 The choice of the most suitable strategy for preserving fertility depends on different parameters: the type and timing of chemotherapy, the type of cancer, the patient’s age, and the partner status. According to the Ethics Committee of the American Society for Reproductive Medicine (ASRM),⁷ the only established method of fertility preservation is embryo cryopreservation, but this option requires the patient to be of pubertal age, have a partner or use donor sperm, and be able to undergo a cycle of ovarian stimulation.

To read full article please click here.